Selecting the Substantially Touched Vertebra as the Lowest Instrumented Vertebra in Spinal Surgeries for B3GALT6-Related Disorders: Clinical Experience and Literature Review

Abstract

Objectives: B3GALT6-related disorders are characterized by severe early-onset spinal deformities requiring surgical corrections but are associated with increased risks of perioperative complications. This study reports the clinical experience and outcomes of selecting the substantially touched vertebra (STV) as the lowest instrumented vertebra (LIV) in spinal surgeries for patients with B3GALT6-related disorders, a group of extremely rare skeletal and connective tissue disorders.

Methods: This retrospective study included patients who were molecularly diagnosed with B3GALT6-related disorders and received spinal surgeries for (kypho)scoliosis between 2017 and June 2023. Their medical records were reviewed. We also conducted a systematic literature review to identify (kypho)scoliosis management in patients with B3GALT6-related disorders.

Results: We identified a total of four patients. Patient 1 presented with severe kyphoscoliosis and segmentation defects and received a pedicle subtraction osteotomy with short fusion and dual growing rods from T3 to L3. However, coronal imbalance was observed at the 18-month follow-up. Genetic testing revealed biallelic disease-causing variants in B3GALT6. A revision surgery was successfully performed, with the level of the LIV extended to the STV (L4). The LIV was similarly extended to the STV in the index surgery for subsequent Patients 2 and 3 who received preoperative genetic testing results, and no complication has been observed. Patient 4 underwent preoperative Halo-pelvic traction to minimize complications, followed by posterior spinal fusion. The curves were successfully reduced without complications. A systematic literature review identified 86 articles reporting (kypho) scoliosis management in 12 of the 63 patients with B3GALT6-related disorders. Limited surgical experience has been reported, with an increased rate of complications, including death.

Conclusions: Selecting the STV as the LIV is recommended in spinal surgeries for patients with B3GALT6-related disorders, considering the characteristic joint hypermobility associated with the condition. Additionally, preoperative Halo-pelvic traction may also be safe and effective. Furthermore, preoperative molecular diagnosis is essential for enabling precision medicine and minimizing complications.

Keywords

Ehlers-Danlos syndrome / genetic testing / joint instability / operative / scoliosis / surgical procedures

References

[1] R. El-Hawary and B. A. Akbarnia, “Early Onset Scoliosis-Time for Consensus,” Spine Deformity 3, no. 2 (2015): 105-106, https://doi.org/10.1016/j.jspd.2015.01.003.

[2] B. A. Williams, H. Matsumoto, D. J. McCalla, et al., “Development and Initial Validation of the Classification of Early-Onset Scoliosis (C-EOS),” Journal of Bone and Joint Surgery (American Volume) 96, no. 16 (2014): 1359-1367, https://doi.org/10.2106/JBJS.M.00253.

[3] A. S. Chung, S. Renfree, D. B. Lockwood, J. Karlen, and M. Belthur, “Syndromic Scoliosis: National Trends in Surgical Management and Inpatient Hospital Outcomes: A 12-Year Analysis,” Spine (Phila Pa 1976) 44, no. 22 (2019): 1564-1570, https://doi.org/10.1097/BRS.0000000000003134.

[4] B. J. Levy, J. F. Schulz, E. D. Fornari, and A. L. Wollowick, “Complications Associated With Surgical Repair of Syndromic Scoliosis,” Scoliosis 10 (2015): 14, https://doi.org/10.1186/s13013-015-0035-x.

[5] X. Bai, D. Zhou, J. R. Brown, B. E. Crawford, T. Hennet, and J. D. Esko, “Biosynthesis of the Linkage Region of Glycosaminoglycans: Cloning and Activity of Galactosyltransferase II, the Sixth Member of the Beta 1,3-Galactosyltransferase Family (Beta 3GalT6),” Journal of Biological Chemistry 276, no. 51 (2001): 48189-48195, https://doi.org/10.1074/jbc.M107339200.

[6] D. Syx, S. Delbaere, C. Bui, et al., “Alterations in Glycosaminoglycan Biosynthesis Associated With the Ehlers-Danlos Syndromes,” American Journal of Physiology. Cell Physiology 323, no. 6 (2022): C1843-C1859, https://doi.org/10.1152/ajpcell.00127.2022.

[7] J. R. Couchman and C. A. Pataki, “An Introduction to Proteoglycans and Their Localization,” Journal of Histochemistry and Cytochemistry 60, no. 12 (2012): 885-897, https://doi.org/10.1369/0022155412464638.

[8] T. Van Damme, X. Pang, B. Guillemyn, et al., “Biallelic B3GALT6 Mutations Cause Spondylodysplastic Ehlers-Danlos Syndrome,” Human Molecular Genetics 27, no. 20 (2018): 3475-3487, https://doi.org/10.1093/hmg/ddy234.

[9] L. I. al Gazali, J. al Talabani, A. Mosawi, and W. Lytle, “Anterior Segment Anomalies of the Eye, Clefting and Skeletal Abnormalities in Two Sibs of Consanguineous Parents: Michels Syndrome or New Syndrome?,” Clinical Dysmorphology 3, no. 3 (1994): 238-244.

[10] A. Ben-Mahmoud, S. Ben-Salem, M. Al-Sorkhy, A. John, B. R. Ali, and L. Al-Gazali, “A B3GALT6 Variant in Patient Originally Described as Al-Gazali Syndrome and Implicating the Endoplasmic Reticulum Quality Control in the Mechanism of Some beta3GalT6-Pathy Mutations,” Clinical Genetics 93, no. 6 (2018): 1148-1158, https://doi.org/10.1111/cge.13236.

[11] F. Malfait, M. Castori, C. A. Francomano, C. Giunta, T. Kosho, and P. H. Byers, “The Ehlers-Danlos Syndromes,” Nature Reviews Disease Primers 6, no. 1 (2020): 64, https://doi.org/10.1038/s41572-020-0194-9.

[12] N. Hadar, O. Porgador, I. Cohen, et al., “Heterozygous THBS2 Pathogenic Variant Causes Ehlers-Danlos Syndrome With Prominent Vascular Features in Humans and Mice,” European Journal of Human Genetics 32, no. 5 (2024): 550-557, https://doi.org/10.1038/s41431-024-01559-1.

[13] F. Malfait, C. Francomano, P. Byers, et al., “The 2017 International Classification of the Ehlers-Danlos Syndromes,” American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 175, no. 1 (2017): 8-26, https://doi.org/10.1002/ajmg.c.31552.

[14] W. Smith, H. P. Ji, W. Mouradian, and R. A. Pagon, “Spondyloepimetaphyseal Dysplasia With Joint Laxity (SEMDJL): Presentation in Two Unrelated Patients in the United States,” American Journal of Medical Genetics 86, no. 3 (1999): 245-252.

[15] S. Unger, C. R. Ferreira, G. R. Mortier, et al., “Nosology of Genetic Skeletal Disorders: 2023 Revision,” American Journal of Medical Genetics. Part A 191, no. 5 (2023): 1164-1209, https://doi.org/10.1002/ajmg.a.63132.

[16] F. Taylan and O. Makitie, “Abnormal Proteoglycan Synthesis due to Gene Defects Causes Skeletal Diseases With Overlapping Phenotypes,” Hormone and Metabolic Research 48, no. 11 (2016): 745-754, https://doi.org/10.1055/s-0042-118706.

[17] A. F. Brady, S. Demirdas, S. Fournel-Gigleux, et al., “The Ehlers-Danlos Syndromes, Rare Types,” American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 175, no. 1 (2017): 70-115, https://doi.org/10.1002/ajmg.c.31550.

[18] F. Malfait, “Vascular Aspects of the Ehlers-Danlos Syndromes,” Matrix Biology 71-72 (2018): 380-395, https://doi.org/10.1016/j.matbio.2018.04.013.

[19] S. G. Caraffi, I. Maini, I. Ivanovski, et al., “Severe Peripheral Joint Laxity Is a Distinctive Clinical Feature of Spondylodysplastic-Ehlers-Danlos Syndrome (EDS)-B4GALT7 and Spondylodysplastic-EDS-B3GALT6,” Genes (Basel) 10, no. 10 (2019): 799, https://doi.org/10.3390/genes10100799.

[20] P. Trejo, F. Rauch, F. H. Glorieux, J. Ouellet, T. Benaroch, and P. M. Campeau, “Spondyloepimetaphysial Dysplasia With Joint Laxity in Three Siblings With B3GALT6 Mutations,” Molecular Syndromology 8, no. 6 (2017): 303-307, https://doi.org/10.1159/000479672.

[21] A. A. Vorster, P. Beighton, and R. S. Ramesar, “Spondyloepimetaphyseal Dysplasia With Joint Laxity (Beighton Type); Mutation Analysis in Eight Affected South African Families,” Clinical Genetics 87, no. 5 (2015): 492-495, https://doi.org/10.1111/cge.12413.

[22] P. Beighton and K. Kozlowski, “Spondylo-Epi-Metaphyseal Dysplasia With Joint Laxity and Severe, Progressive Kyphoscoliosis,” Skeletal Radiology 5, no. 4 (1980): 205-212, https://doi.org/10.1007/BF00580591.

[23] N. Chen, S. Zhao, A. Jolly, et al., “Perturbations of Genes Essential for Müllerian Duct and Wölffian Duct Development in Mayer-Rokitansky-Küster-Hauser Syndrome,” American Journal of Human Genetics 108, no. 2 (2021): 337-345, https://doi.org/10.1016/j.ajhg.2020.12.014.

[24] K. Wang, S. Zhao, Z. Xie, et al., “Exome-Wide Analysis of De Novo and Rare Genetic Variants in Patients With Brain Arteriovenous Malformation,” Neurology 98, no. 16 (2022): e1670-e1678, https://doi.org/10.1212/WNL.0000000000200114.

[25] S. Zhao, Y. Zhang, W. Chen, et al., “Diagnostic Yield and Clinical Impact of Exome Sequencing in Early-Onset Scoliosis (EOS),” Journal of Medical Genetics 58, no. 1 (2021): 41-47, https://doi.org/10.1136/jmedgenet-2019-106823.

[26] S. Richards, N. Aziz, S. Bale, et al., “Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology,” Genetics in Medicine 17, no. 5 (2015): 405-424, https://doi.org/10.1038/gim.2015.30.

[27] E. R. Riggs, E. F. Andersen, A. M. Cherry, et al., “Technical Standards for the Interpretation and Reporting of Constitutional Copy-Number Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen),” Genetics in Medicine 22, no. 2 (2020): 245-257, https://doi.org/10.1038/s41436-019-0686-8.

[28] Y. Wang, C. Li, L. Liu, H. Li, and X. Yi, “Presurgical Short-Term Halo-Pelvic Traction for Severe Rigid Scoliosis (Cobb Angle >120 Degrees): A 2-Year Follow-Up Review of 62 Patients,” Spine (Phila Pa 1976) 46, no. 2 (2021): E95-E104, https://doi.org/10.1097/BRS.0000000000003740.

[29] S. Wang, J. Zhang, G. Qiu, Y. Wang, X. Weng, and J. Guo, “One-Stage Posterior Osteotomy With Short Segmental Fusion and Dual Growing Rod Technique for Severe Rigid Congenital Scoliosis: The Preliminary Clinical Outcomes of a Hybrid Technique,” Spine (Phila Pa 1976) 39, no. 4 (2014): E294-E299, https://doi.org/10.1097/BRS.0000000000000119.

[30] S. Wang, J. Zhang, G. Qiu, et al., “Dual Growing Rods Technique for Congenital Scoliosis: More Than 2 Years Outcomes: Preliminary Results of a Single Center,” Spine (Phila Pa 1976) 37, no. 26 (2012): E1639-E1644, https://doi.org/10.1097/BRS.0b013e318273d6bf.

[31] H. Wang, S. Wang, N. Wu, S. Wang, G. Qiu, and J. Zhang, “Posterior Vertebral Column Resection (pVCR) for Severe Thoracolumbar Kyphosis in Patients With Achondroplasia,” Global Spine Journal 12, no. 8 (2022): 1804-1813, https://doi.org/10.1177/2192568221989291.

[32] Chinese Multi-Disciplinary Working Group on the Ehlers-Danlos Syndromes, “Chinese Guidelines for Diagnosis and Treatment of the Ehlers-Danlos Syndromes,” Journal of Rare Diseases 2, no. 4 (2023): 554-588, https://doi.org/10.12376/j.issn.2097-0501.2023.04.013.

[33] N. Meng, J. P. Y. Cheung, K. K. Wong, et al., “An Artificial Intelligence Powered Platform for Auto-Analyses of Spine Alignment Irrespective of Image Quality With Prospective Validation,” EClinicalMedicine 43 (2022): 101252, https://doi.org/10.1016/j.eclinm.2021.101252.

[34] K. C. Coetzer, J. Dieckerhoff, B. Wollnik, and S. Moosa, “B3GALT6-Linkeropathy: Three Illustrative Patients Spanning the Disease Spectrum,” European Journal of Medical Genetics 66, no. 10 (2023): 104829, https://doi.org/10.1016/j.ejmg.2023.104829.

[35] M. Nakajima, S. Mizumoto, N. Miyake, et al., “Mutations in B3GALT6, Which Encodes a Glycosaminoglycan Linker Region Enzyme, Cause a Spectrum of Skeletal and Connective Tissue Disorders,” American Journal of Human Genetics 92, no. 6 (2013): 927-934, https://doi.org/10.1016/j.ajhg.2013.04.003.

[36] E. M. Honey, “Spondyloepimetaphyseal Dysplasia With Joint Laxity (Beighton Type): A Unique South African Disorder,” South African Medical Journal 106, no. 6 Suppl 1 (2016): S54-S56, https://doi.org/10.7196/SAMJ.2016.v106i6.10994.

[37] P. Beighton, G. Gericke, K. Kozlowski, and L. Grobler, “The Manifestations and Natural History of Spondylo-Epi-Metaphyseal Dysplasia With Joint Laxity,” Clinical Genetics 26, no. 4 (1984): 308-317, https://doi.org/10.1111/j.1399-0004.1984.tb01065.x.

[38] S. Bess, B. A. Akbarnia, G. H. Thompson, et al., “Complications of Growing-Rod Treatment for Early-Onset Scoliosis: Analysis of One Hundred and Forty Patients,” Journal of Bone and Joint Surgery (American Volume) 92, no. 15 (2010): 2533-2543, https://doi.org/10.2106/JBJS.I.01471.

[39] M. L. Toumia, A. A. Mohseni, M. N. Nessib, R. Boussetta, H. Yacoub-Youssef, and S. Bouchoucha, “Growing Rods for Early-Onset Scoliosis in Ehlers-Danlos Disease,” Spine Deformity 11, no. 1 (2023): 237-242, https://doi.org/10.1007/s43390-022-00580-y.

[40] J. P. Y. Cheung, K. Yiu, K. Kwan, and K. M. C. Cheung, “Mean 6-Year Follow-Up of Magnetically Controlled Growing Rod Patients With Early Onset Scoliosis: A Glimpse of What Happens to Graduates,” Neurosurgery 84, no. 5 (2019): 1112-1123, https://doi.org/10.1093/neuros/nyy270.

[41] B. M. Rabenhorst, S. Garg, and J. A. Herring, “Posterior Spinal Fusion in Patients With Ehlers-Danlos Syndrome: A Report of Six Cases,” Journal of Children's Orthopaedics 6, no. 2 (2012): 131-136, https://doi.org/10.1007/s11832-012-0393-3.

[42] A. M. Alazami, S. M. Al-Qattan, E. Faqeih, et al., “Expanding the Clinical and Genetic Heterogeneity of Hereditary Disorders of Connective Tissue,” Human Genetics 135, no. 5 (2016): 525-540, https://doi.org/10.1007/s00439-016-1660-z.

[43] P. O. Newton and G. Harms Study, Idiopathic Scoliosis: The Harms Study Group Treatment Guide (Thieme, 2010).

[44] S. Ifthekar, K. Ahuja, P. V. Sudhakar, et al., “Is It Safe to Save Levels and Choose the Lowest Instrumented Vertebra as Touched Vertebra While Selectively Fusing Lenke 1/2 Curves? A Proportional Meta-Analysis of Existing Evidence,” Global Spine Journal 13, no. 1 (2023): 219-226, https://doi.org/10.1177/21925682221091744.

[45] E. C. Beauchamp, L. G. Lenke, M. Cerpa, et al., “Selecting the “Touched Vertebra” as the Lowest Instrumented Vertebra in Patients With Lenke Type-1 and 2 Curves: Radiographic Results After a Minimum 5-Year Follow-Up,” Journal of Bone and Joint Surgery (American Volume) 102, no. 22 (2020): 1966-1973, https://doi.org/10.2106/JBJS.19.01485.

[46] X. Qin, W. Sun, L. Xu, Z. Liu, Y. Qiu, and Z. Zhu, “Selecting the Last “Substantially” Touching Vertebra as Lowest Instrumented Vertebra in Lenke Type 1A Curve: Radiographic Outcomes With a Minimum of 2-Year Follow-Up,” Spine (Phila Pa 1976) 41, no. 12 (2016): E742-E750, https://doi.org/10.1097/BRS.0000000000001374.

[47] T. J. Buell, S. Bess, M. Xu, et al., “Optimal Tether Configurations and Preload Tensioning to Prevent Proximal Junctional Kyphosis: A Finite Element Analysis,” Journal of Neurosurgery: Spine 30, no. 5 (2019): 1-11, https://doi.org/10.3171/2018.10.SPINE18429.

[48] K. Xu, G. Li, Z. Wu, T. J. Zhang, N. Wu, and Chinese Multi-Disciplinary Working Group on the Ehlers-Danlos S, “Diagnosis and Treatment of the Ehlers-Danlos Syndromes in China: Synopsis of the First Guidelines,” Orphanet Journal of Rare Diseases 19, no. 1 (2024): 194, https://doi.org/10.1186/s13023-024-03121-0.

[49] L. Ashebo, J. B. Anari, and P. J. Cahill, “Update on the Diagnosis and Management of Early-Onset Scoliosis,” Current Reviews in Musculoskeletal Medicine 16, no. 10 (2023): 447-456, https://doi.org/10.1007/s12178-023-09848-w.

[50] K. A. Zapata, D. J. Sucato, and C. H. Jo, “Physical Therapy Scoliosis-Specific Exercises May Reduce Curve Progression in Mild Adolescent Idiopathic Scoliosis Curves,” Pediatric Physical Therapy 31, no. 3 (2019): 280-285, https://doi.org/10.1097/PEP.0000000000000621.

[51] S. Delbaere, A. De Clercq, S. Mizumoto, et al., “b3galt6 Knock-Out Zebrafish Recapitulate beta3GalT6-Deficiency Disorders in Human and Reveal a Trisaccharide Proteoglycan Linkage Region,” Frontiers in Cell and Development Biology 8 (2020): 597857, https://doi.org/10.3389/fcell.2020.597857.

[52] M. Maghnie, M. B. Ranke, M. E. Geffner, et al., “Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort,” Journal of Clinical Endocrinology and Metabolism 107, no. 12 (2022): 3287-3301, https://doi.org/10.1210/clinem/dgac517.

[53] R. K. Haidar, M. P. Nasrallah, A. H. Der-Boghossian, and I. B. Ghanem, “Orthopedic Complications Related to Growth Hormone Therapy in a Pediatric Population,” Journal of Pediatric Orthopaedics. Part B 20, no. 1 (2011): 57-61, https://doi.org/10.1097/BPB.0b013e32833ed967.

RIGHTS & PERMISSIONS

2025 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.